CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 87 enrolled
Drug / intervention
None, observational study only (no interventions)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04254575
NCT04254575N/ACompleted
CompareCT.gov

Smartphone-based Digital Phenotyping to Detect High-risk Affect States in Body Dysmorphic Disorder (BDD)

Massachusetts General Hospital·observational·Posted Feb 5, 2020·Updated Sep 21, 2023

In Brief

An observational study evaluating None, observational study only (no interventions) for Body Dysmorphic Disorders. Completed, enrolled 87 participants across 1 site.

Detailed Summary

Body dysmorphic disorder (BDD) is associated with high risk for suicide attempts (22-28%) and substance use disorders (49%), underscoring the importance of accurate, real-time risk detection in BDD. This study aims to use smartphone-based digital phenotyping to develop and validate unobtrusive, time-sensitive, and ecologically valid measures of key risk factors for suicide and substance misuse in BDD: negative affect states. As next steps, this research can be extended to detect risk transdiagnostically, with the goal of enabling just-in-time interventions to target suicide and substance misuse across psychiatric illnesses.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBody Dysmorphic Disorders
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 5, 2020
Enrollment StartJul 15, 2020
Primary CompletionApr 28, 2023
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 6.4 years ago

Interventions

None, observational study only (no interventions)other

None, observational study only (no interventions)